Osimertinib resistance in non-small cell lung cancer: Pathways and potential solutions AJE Video Bytes 1:41 1 year ago 3 476 Далее Скачать
Dr. Carbone on Acquired Resistance to Osimertinib in NSCLC OncLive 1:06 4 years ago 595 Далее Скачать
Quickfire Updates From Chicago: What’s New for EGFR TKI Refractory and Resistant Non-Small Cell L... Medscape 19:19 7 months ago 11 Далее Скачать
Dr. Padda on Overcoming Resistance to Osimertinib in EGFR+ NSCLC OncLive 1:43 5 years ago 3 339 Далее Скачать
EGFR: The Challenge of Primary and Secondary Resistance HMP Education 44:03 1 year ago 1 102 Далее Скачать
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer U.S. Food and Drug Administration 6:01 9 months ago 61 Далее Скачать
Resistance Mechanisms in EGFR+ NSCLC Treatment - Targeted Therapies in Lung Cancer 2023 GRACE - Global Resource for Advancing Cancer Education 3:02 1 year ago 82 Далее Скачать
Acquired Resistance to Osimertinib in EGFR+ NSCLC - 2022 Program: Targeted Therapies Forum - English GRACE - Global Resource for Advancing Cancer Education 2:30 2 years ago 638 Далее Скачать
Dr. Goldberg on Options After Developing Resistance to Osimertinib for NSCLC OncLive 1:16 6 years ago 1 512 Далее Скачать
Tagrisso (osimertinib)- non-small cell lung cancer (NSCLC) Pharmacy Talk USA 1:48 1 year ago 224 Далее Скачать
Dr. Ramalingam on the Role of Osimertinib in eGFR T790M-Positive Advanced NSCLC OncLive 1:40 8 years ago 730 Далее Скачать
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer ecancer 3:31 4 years ago 2 161 Далее Скачать
Osimertinib and the FLAURA Trial GRACE - Global Resource for Advancing Cancer Education 5:42 2 years ago 260 Далее Скачать
Gene Targeted Therapy for Non Small Cell Lung Cancer Chief Fellow 59:01 7 years ago 735 Далее Скачать
